MedTrace Logo

Coronary Artery Disease: a Case- Control Study

NCT03075566 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 517

Last updated 2017-03-09

No results posted yet for this study

Summary

Atherosclerosis is a chronic inflammatory condition, which is associated by the involvement of several pathological events, and alteration in the serum levels of pro- and anti-inflammatory, and lipid markers.

The investigators evaluated the contribution of serum biomarkers levels to the pathogenesis of coronary artery disease, namely their association with risk factors, clinical presentation, extent and severity of atherosclerotic changes accompanying coronary artery disease.

Conditions

Interventions

BIOLOGICAL

Healthy subjects

\- 207 healthy subjects were donors,(33.2±12.2 years) recruited from the Blood Bank Department of the University Hospital (Mahdia, Tunisia).

BIOLOGICAL

Patients

\- 310 subjects with CAD (60.3±11.0 years) were admitted to the Department of Cardiology, University Hospital (Monastir, Tunisia).

Sponsors & Collaborators

  • Nadia Bouzidi, PhD

    lead OTHER

Principal Investigators

  • Salima Ferchichi, Pr · University of Monastir, Faculty of Pharmacy of Monastir, Tunisia

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2017-09-30
Completion
2017-12-31
FDA Drug
Yes

Countries

  • Tunisia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03075566 on ClinicalTrials.gov